Sign In
Buy CRSP
$46.99
-0.790 (-1.65%)
At Close: Jul 20, 2026
Where Will CRISPR Therapeutics Be in 1 Year?
03:00pm, Sunday, 31'st Jul 2022 The Motley Fool
The next 12 months could look very different from the past year for this biotech company.
Where Will CRISPR Therapeutics Be in 1 Year?
11:00am, Sunday, 31'st Jul 2022
The next 12 months could look very different from the past year for this biotech company.
2 Biotech Stocks That Could Help Make You a Fortune
10:15am, Saturday, 30'th Jul 2022 The Motley Fool
These companies have seen triple-digit revenue growth in recent years.
Intellia Therapeutics Is Pushing CRISPR-Based Therapy Forward, Slowly But Surely
05:31am, Saturday, 30'th Jul 2022 Seeking Alpha
Intellia’s recent data from its Regeneron collaboration for CRISPR-based NTLA-2001 shows a durable response to the lead in vivo genome editing candidate.
Vertex (VRTX) to Report Q2 Earnings: What's in the Cards?
07:51pm, Friday, 29'th Jul 2022 Zacks Investment Research
On Vertex Pharmaceuticals' (VRTX) Q2 earnings call, investors are most likely to focus on the sales performance of its cystic fibrosis (CF) medicines and updates on its non-CF pipeline candidates.
Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
11:19am, Friday, 29'th Jul 2022
This article reviews the current state of affairs for CRISPR Therapeutics so you can decide if the gene editing company is worth a speculative investment
CRISPR (CRSP) to Report Q2 Earnings: What's in the Cards?
04:19pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
On CRISPR Therapeutics' (CRSP) Q2 earnings call, investors will look for updates on its pipeline candidates, especially its lead candidate exa-cel.
Should You Buy Beaten-Down Biotech Stocks & ETFs?
06:32pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
We highlight 4 ETFs that have started rebounding after a brutal sell-off
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
10:00pm, Monday, 25'th Jul 2022 Zacks Investment Research
CRISPR Therapeutics AG (CRSP) closed at $76.50 in the latest trading session, marking a +0.9% move from the prior day.
Crispr Therapeutics' Continued Progress Warrants A Buy
04:23pm, Monday, 25'th Jul 2022
Crispr Therapeutics continues to make progress toward submitting a global regulatory filing for CTX001. CTX130 preliminary data shows the power of Crispr Cas-9 technology.
2 Biotech Stocks to Help Recession-Proof Your Portfolio
02:45pm, Friday, 22'nd Jul 2022 The Motley Fool
These companies' shares have outpaced the market and other biotech stocks this year.
2 Biotech Stocks to Help Recession-Proof Your Portfolio
10:45am, Friday, 22'nd Jul 2022
These companies' shares have outpaced the market and other biotech stocks this year.
2 Unstoppable Growth Stocks to Buy and Hold for Decades
02:45pm, Thursday, 21'st Jul 2022 The Motley Fool
These businesses are full of growth potential.
Down 35% This Year, Is This Small-Cap Stock a Buy?
02:30pm, Thursday, 21'st Jul 2022 The Motley Fool
This biotech could be a steal at its current levels, but it could also be a trap.
If You Invested $5,000 in Vertex Pharmaceuticals in 2017, This Is How Much You Would Have Today
10:00am, Wednesday, 20'th Jul 2022 The Motley Fool
Your investment would have been a winning one.
